Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 5/20 | 0.61 |
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | ELANE | P08246 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | MAPT | P10636 | 6/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.52 |
| ▸ | RECQL | P46063 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | USP2 | O75604 | 3/20 | 0.52 |
| ▸ | BRCA1 | P38398 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31265528 | 1.00 | LCK (0.67) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL27796804 | 0.85 | TTR (0.70) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL24148896 | 0.85 | TTR (0.70) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL5981382 | 0.84 | ELANE (0.69) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL30610009 | 0.84 | ELANE (0.69) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL29405931 | 0.84 | ELANE (0.69) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL29435136 | 0.84 | ELANE (0.69) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL9353826 | 0.81 | MAOA (0.68) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL11080514 | 0.81 | LCK (0.68) | LCKMAOAMAOBELANEMEN1 | |
| SCHEMBL7172505 | 0.80 | LCK (1.00) | LCKMAOAMAOBELANEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-1538154-B1 | Quencher composition comprising anthraquinone moieties | EXIQON AS (DK) | 2008-12-31 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | disclosed |
| US-20140227689-A1 | NOVEL METHODS FOR QUANTIFICATION OF MICRORNAS AND SMALL INTERFERING RNAS | EXIQON A/S (DK) | 2014-08-14 | — | — | US | disclosed |
| US-8394512-B2 | Phosphaphenanthrene compounds and organic light emitting diode using the same | INKTEC CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394512-B2 | Phosphaphenanthrene compounds and organic light emitting diode using the same | INKTEC CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8394512-B2 | Phosphaphenanthrene compounds and organic light emitting diode using the same | INKTEC CO., LTD. (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8383344-B2 | Methods for quantification of microRNAs and small interfering RNAs | EXIQON A/S (DK) | 2013-02-26 | — | — | US | disclosed |
| CN-1961081-B | Methods for quantification of microRNA and small interfering RNA | EXIQON AS | 2012-09-05 | — | — | CN | disclosed |
| US-8192937-B2 | Methods for quantification of microRNAs and small interfering RNAs | EXIQON A/S (DK) | 2012-06-05 | — | — | US | disclosed |
| EP-1735459-B1 | METHODS FOR QUANTIFICATION OF MICRORNAS AND SMALL INTERFERING RNAS | EXIQON AS (DK) | 2012-01-25 | — | — | EP | disclosed |
| WO-2005098029-A2 | METHODS FOR QUANTIFICATION OF MICRORNAS AND SMALL INTERFERING RNAS | EXIQON A/S (DK) | 2005-10-20 | — | — | WO | disclosed |
| US-20050227254-A1 | Quencher compositions comprising anthraquinone moieties | QIAGEN GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-1538154-A1 | Quencher composition comprising anthraquinone moieties | Exiqon A/S (DK) | 2005-06-08 | — | — | EP | disclosed |
| US-5484935-A | Pharmaceutical compounds | LILLY INDUSTRIES LIMITED (GB) | 1996-01-16 | — | — | US | disclosed |
| EP-0638562-A1 | Anthraquinone derivatives useful in the treatment of cancer and osteoartritis | LILLY INDUSTRIES LIMITED (GB) | 1995-02-15 | — | — | EP | disclosed |
| EP-0125311-B1 | POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-01-20 | — | — | EP | disclosed |
| EP-0125311-A1 | POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS. | EASTMAN KODAK CO (US) | 1984-11-21 | — | — | EP | disclosed |
| WO-1984002136-A2 | POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS | EASTMAN KODAK CO (US) | 1984-06-07 | — | — | WO | disclosed |
| US-4403092-A | COLORFAST FOOD CONTAINERS | EASTMAN KODAK COMPANY (US) | 1983-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227254-A1 | Quencher compositions comprising anthraquinone moieties | ANXA5, SUN2, ANXA3 | LCK 4263/4885MAOA 4699/4885MAOB 4296/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | LCK 4305/4885MAOA 3628/4885MAOB 3075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.